Financial Results - ABVC BioPharma, Inc. announced its financial results for the fiscal year ended December 31, 2024, in a press release issued on April 15, 2025[4]. Financial Misstatements - The company identified material misstatements in its financial statements for the fiscal year ended December 31, 2023, due to errors in accounting guidance and recognition of expenses[7]. - The misstatements affected key financial metrics including construction in progress, carrying value of convertible notes payable, and stock-based compensation[8]. - The company plans to file an amendment to its Annual Report on Form 10-K to address the identified errors and their impacts[9]. Internal Controls - ABVC BioPharma's Audit Committee has acknowledged a material weakness in its internal controls over financial reporting[10].
ABVC BioPharma(ABVC) - 2025 Q1 - Quarterly Results